ELECTROVEST: Electro-Stimulation Vibratory Vest for Pulmonary Rehabilitation in Patients With Chronic Respiratory Diseases

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

March 7, 2025

Study Completion Date

May 20, 2025

Conditions
COPD (Chronic Obstructive Pulmonary Disease)Cystic Fibrosis (CF)Bronchiectasis AdultAsthma Bronchiale
Interventions
DEVICE

ELECTROVEST

A wearable vest device that delivers airway clearance therapy through high-frequency chest wall oscillation (HFCWO) combined with surface neuromuscular electrostimulation (EEM). The session includes a 2-minute warm-up phase at 4 Hz, 16 minutes of active stimulation at 8 Hz, and a 2-minute recovery phase at 4 Hz (total duration: 20 minutes). The intervention is administered during supervised physiotherapy sessions to promote mucociliary clearance and respiratory muscle activation in patients with chronic respiratory diseases.

DEVICE

The Vest® Model 105

A conventional airway clearance therapy using a commercial high-frequency chest wall oscillation (HFCWO) device (The Vest® Model 105 or AffloVest®). The session includes a 2-minute warm-up phase at 13 Hz, 16 minutes of treatment at 20 Hz, and a 2-minute cool-down at 13 Hz (total duration: 20 minutes). This intervention serves as the active comparator in the crossover trial.

Trial Locations (1)

41013

Hospital Universitario Virgen del Rocío, Seville

All Listed Sponsors
collaborator

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

OTHER

lead

Hospitales Universitarios Virgen del Rocío

OTHER

NCT07175012 - ELECTROVEST: Electro-Stimulation Vibratory Vest for Pulmonary Rehabilitation in Patients With Chronic Respiratory Diseases | Biotech Hunter | Biotech Hunter